Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 13, no: 2 |
NetGPI | no | yes: 0, no: 15 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
Related structures:
AlphaFold database: E9AHU3
Term | Name | Level | Count |
---|---|---|---|
GO:0008152 | metabolic process | 1 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 13 |
GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds | 4 | 2 |
GO:0004564 | beta-fructofuranosidase activity | 5 | 2 |
GO:0016787 | hydrolase activity | 2 | 13 |
GO:0016798 | hydrolase activity, acting on glycosyl bonds | 3 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
DEG_SCF_FBW7_1 | 159 | 166 | PF00400 | 0.158 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 211 | 220 | PF00134 | 0.158 |
DOC_MAPK_MEF2A_6 | 294 | 301 | PF00069 | 0.424 |
DOC_MAPK_NFAT4_5 | 294 | 302 | PF00069 | 0.158 |
DOC_PP1_RVXF_1 | 37 | 43 | PF00149 | 0.158 |
DOC_PP2B_PxIxI_1 | 318 | 324 | PF00149 | 0.191 |
DOC_PP4_FxxP_1 | 137 | 140 | PF00568 | 0.158 |
DOC_PP4_FxxP_1 | 69 | 72 | PF00568 | 0.158 |
DOC_SPAK_OSR1_1 | 307 | 311 | PF12202 | 0.309 |
DOC_USP7_MATH_1 | 285 | 289 | PF00917 | 0.469 |
DOC_WW_Pin1_4 | 159 | 164 | PF00397 | 0.203 |
DOC_WW_Pin1_4 | 214 | 219 | PF00397 | 0.403 |
DOC_WW_Pin1_4 | 324 | 329 | PF00397 | 0.344 |
DOC_WW_Pin1_4 | 64 | 69 | PF00397 | 0.391 |
DOC_WW_Pin1_4 | 73 | 78 | PF00397 | 0.275 |
LIG_14-3-3_CanoR_1 | 104 | 112 | PF00244 | 0.332 |
LIG_14-3-3_CanoR_1 | 92 | 98 | PF00244 | 0.304 |
LIG_BRCT_BRCA1_1 | 114 | 118 | PF00533 | 0.453 |
LIG_BRCT_BRCA1_1 | 121 | 125 | PF00533 | 0.452 |
LIG_BRCT_BRCA1_1 | 304 | 308 | PF00533 | 0.263 |
LIG_FHA_1 | 112 | 118 | PF00498 | 0.220 |
LIG_FHA_1 | 141 | 147 | PF00498 | 0.175 |
LIG_FHA_1 | 211 | 217 | PF00498 | 0.206 |
LIG_FHA_1 | 285 | 291 | PF00498 | 0.216 |
LIG_FHA_1 | 343 | 349 | PF00498 | 0.367 |
LIG_FHA_1 | 83 | 89 | PF00498 | 0.366 |
LIG_FHA_2 | 111 | 117 | PF00498 | 0.179 |
LIG_FHA_2 | 221 | 227 | PF00498 | 0.182 |
LIG_FXI_DFP_1 | 338 | 342 | PF00024 | 0.189 |
LIG_IRF3_LxIS_1 | 25 | 31 | PF10401 | 0.369 |
LIG_LIR_Apic_2 | 134 | 140 | PF02991 | 0.158 |
LIG_LIR_Apic_2 | 274 | 280 | PF02991 | 0.177 |
LIG_LIR_Apic_2 | 67 | 72 | PF02991 | 0.262 |
LIG_LIR_Gen_1 | 122 | 131 | PF02991 | 0.427 |
LIG_LIR_Gen_1 | 305 | 316 | PF02991 | 0.264 |
LIG_LIR_Gen_1 | 94 | 99 | PF02991 | 0.171 |
LIG_LIR_Nem_3 | 115 | 121 | PF02991 | 0.355 |
LIG_LIR_Nem_3 | 122 | 128 | PF02991 | 0.395 |
LIG_LIR_Nem_3 | 175 | 180 | PF02991 | 0.199 |
LIG_LIR_Nem_3 | 259 | 264 | PF02991 | 0.395 |
LIG_LIR_Nem_3 | 305 | 311 | PF02991 | 0.343 |
LIG_LIR_Nem_3 | 94 | 98 | PF02991 | 0.178 |
LIG_MAD2 | 127 | 135 | PF02301 | 0.158 |
LIG_MLH1_MIPbox_1 | 121 | 125 | PF16413 | 0.158 |
LIG_PCNA_PIPBox_1 | 170 | 179 | PF02747 | 0.158 |
LIG_PCNA_yPIPBox_3 | 257 | 266 | PF02747 | 0.158 |
LIG_Pex14_1 | 278 | 282 | PF04695 | 0.307 |
LIG_Pex14_2 | 98 | 102 | PF04695 | 0.158 |
LIG_PTB_Apo_2 | 151 | 158 | PF02174 | 0.176 |
LIG_SH2_CRK | 177 | 181 | PF00017 | 0.427 |
LIG_SH2_CRK | 194 | 198 | PF00017 | 0.156 |
LIG_SH2_CRK | 286 | 290 | PF00017 | 0.373 |
LIG_SH2_GRB2like | 282 | 285 | PF00017 | 0.158 |
LIG_SH2_NCK_1 | 48 | 52 | PF00017 | 0.249 |
LIG_SH2_SRC | 282 | 285 | PF00017 | 0.158 |
LIG_SH2_SRC | 336 | 339 | PF00017 | 0.230 |
LIG_SH2_SRC | 48 | 51 | PF00017 | 0.205 |
LIG_SH2_STAP1 | 286 | 290 | PF00017 | 0.423 |
LIG_SH2_STAP1 | 95 | 99 | PF00017 | 0.249 |
LIG_SH2_STAT3 | 330 | 333 | PF00017 | 0.240 |
LIG_SH2_STAT5 | 124 | 127 | PF00017 | 0.208 |
LIG_SH2_STAT5 | 155 | 158 | PF00017 | 0.292 |
LIG_SH2_STAT5 | 286 | 289 | PF00017 | 0.253 |
LIG_SH2_STAT5 | 336 | 339 | PF00017 | 0.349 |
LIG_SH2_STAT5 | 95 | 98 | PF00017 | 0.386 |
LIG_SH3_3 | 114 | 120 | PF00018 | 0.158 |
LIG_SH3_3 | 215 | 221 | PF00018 | 0.376 |
LIG_SH3_3 | 252 | 258 | PF00018 | 0.158 |
LIG_SH3_4 | 279 | 286 | PF00018 | 0.176 |
LIG_SUMO_SIM_anti_2 | 295 | 300 | PF11976 | 0.472 |
LIG_SUMO_SIM_par_1 | 127 | 132 | PF11976 | 0.253 |
LIG_SUMO_SIM_par_1 | 79 | 87 | PF11976 | 0.158 |
LIG_TRFH_1 | 214 | 218 | PF08558 | 0.282 |
MOD_CK1_1 | 108 | 114 | PF00069 | 0.227 |
MOD_CK1_1 | 288 | 294 | PF00069 | 0.398 |
MOD_CK1_1 | 41 | 47 | PF00069 | 0.383 |
MOD_CK2_1 | 362 | 368 | PF00069 | 0.494 |
MOD_GlcNHglycan | 14 | 17 | PF01048 | 0.440 |
MOD_GlcNHglycan | 194 | 197 | PF01048 | 0.291 |
MOD_GlcNHglycan | 198 | 201 | PF01048 | 0.202 |
MOD_GlcNHglycan | 30 | 33 | PF01048 | 0.430 |
MOD_GlcNHglycan | 364 | 367 | PF01048 | 0.537 |
MOD_GlcNHglycan | 55 | 58 | PF01048 | 0.158 |
MOD_GlcNHglycan | 64 | 67 | PF01048 | 0.150 |
MOD_GSK3_1 | 106 | 113 | PF00069 | 0.251 |
MOD_GSK3_1 | 129 | 136 | PF00069 | 0.400 |
MOD_GSK3_1 | 159 | 166 | PF00069 | 0.338 |
MOD_GSK3_1 | 179 | 186 | PF00069 | 0.272 |
MOD_GSK3_1 | 192 | 199 | PF00069 | 0.174 |
MOD_GSK3_1 | 206 | 213 | PF00069 | 0.146 |
MOD_GSK3_1 | 284 | 291 | PF00069 | 0.263 |
MOD_GSK3_1 | 53 | 60 | PF00069 | 0.452 |
MOD_N-GLC_1 | 157 | 162 | PF02516 | 0.324 |
MOD_N-GLC_1 | 180 | 185 | PF02516 | 0.272 |
MOD_N-GLC_1 | 214 | 219 | PF02516 | 0.478 |
MOD_N-GLC_1 | 61 | 66 | PF02516 | 0.345 |
MOD_NEK2_1 | 107 | 112 | PF00069 | 0.382 |
MOD_NEK2_1 | 157 | 162 | PF00069 | 0.357 |
MOD_NEK2_1 | 179 | 184 | PF00069 | 0.241 |
MOD_NEK2_1 | 210 | 215 | PF00069 | 0.252 |
MOD_NEK2_1 | 28 | 33 | PF00069 | 0.393 |
MOD_NEK2_1 | 289 | 294 | PF00069 | 0.317 |
MOD_NEK2_1 | 302 | 307 | PF00069 | 0.362 |
MOD_NEK2_2 | 93 | 98 | PF00069 | 0.205 |
MOD_PIKK_1 | 119 | 125 | PF00454 | 0.226 |
MOD_PIKK_1 | 166 | 172 | PF00454 | 0.338 |
MOD_PIKK_1 | 180 | 186 | PF00454 | 0.184 |
MOD_PKA_2 | 91 | 97 | PF00069 | 0.402 |
MOD_Plk_4 | 141 | 147 | PF00069 | 0.230 |
MOD_Plk_4 | 183 | 189 | PF00069 | 0.469 |
MOD_Plk_4 | 206 | 212 | PF00069 | 0.312 |
MOD_Plk_4 | 285 | 291 | PF00069 | 0.373 |
MOD_Plk_4 | 38 | 44 | PF00069 | 0.275 |
MOD_Plk_4 | 93 | 99 | PF00069 | 0.391 |
MOD_ProDKin_1 | 159 | 165 | PF00069 | 0.203 |
MOD_ProDKin_1 | 214 | 220 | PF00069 | 0.403 |
MOD_ProDKin_1 | 324 | 330 | PF00069 | 0.355 |
MOD_ProDKin_1 | 64 | 70 | PF00069 | 0.391 |
MOD_ProDKin_1 | 73 | 79 | PF00069 | 0.275 |
TRG_DiLeu_BaEn_1 | 175 | 180 | PF01217 | 0.191 |
TRG_DiLeu_BaLyEn_6 | 316 | 321 | PF01217 | 0.227 |
TRG_ENDOCYTIC_2 | 177 | 180 | PF00928 | 0.243 |
TRG_ENDOCYTIC_2 | 194 | 197 | PF00928 | 0.326 |
TRG_ENDOCYTIC_2 | 286 | 289 | PF00928 | 0.329 |
TRG_ENDOCYTIC_2 | 95 | 98 | PF00928 | 0.205 |
TRG_ER_diArg_1 | 351 | 354 | PF00400 | 0.233 |
TRG_NES_CRM1_1 | 119 | 134 | PF08389 | 0.426 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HYJ4 | Leptomonas seymouri | 37% | 73% |
A0A0S4JMD5 | Bodo saltans | 32% | 73% |
A0A1X0PA11 | Trypanosomatidae | 31% | 80% |
A0A1X0PAC3 | Trypanosomatidae | 41% | 72% |
A0A3Q8IHH9 | Leishmania donovani | 36% | 73% |
A0A3R7K6I9 | Trypanosoma rangeli | 36% | 80% |
A0A3R7KT12 | Trypanosoma rangeli | 29% | 72% |
A4HB81 | Leishmania braziliensis | 39% | 73% |
A4IAC9 | Leishmania infantum | 36% | 73% |
C9ZLW4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 37% | 81% |
C9ZLW5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 73% |
E9B5F2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 37% | 73% |
P70158 | Mus musculus | 24% | 84% |
Q3ZC91 | Bos taurus | 25% | 83% |
Q4Q2I1 | Leishmania major | 37% | 72% |
Q54SR8 | Dictyostelium discoideum | 24% | 83% |
Q55GC7 | Dictyostelium discoideum | 25% | 85% |
Q641Z7 | Rattus norvegicus | 24% | 84% |
Q92484 | Homo sapiens | 25% | 82% |
Q92485 | Homo sapiens | 25% | 82% |
V5DMV6 | Trypanosoma cruzi | 30% | 73% |